Hodgkin's lymphoma Flashcards
List some DDx for a presentation of:
- fever, night sweats (3/52)
- dry cough, nil pharyngitis
- R cervical lymphadenopathy, non-tender
PDx. Hodgkin's lymphoma DDx. Reactive lymphoma (prev URTI) - viral: EBV, CMV, adenovirus - bacterial: strep pneumoniae, staph aureus, TB - AI: SLE, RA Thyroid- Hashimoto's Neoplasm - primary: lymphoma (HL 40% , NHL 60%), leukaemia (ALL, CLL) - secondary: head/neck primary mets Drugs- pheyntoin
What investigations would you order?
Diagnostic: - excisional biopsy - flow cytometry Bedside - nasopharyngeal swab MCS, EBV monospot Lab: - FBC (anaemia of chronic disease) - blood smear (blasts) - CRP/ESR - EUC (hyperuricaemia in increased cell turnover) - lactate dehydrogenase (LDH) (high cell turnover) - LFT - AI panel: ANA, anti-phospholipid Abs, anti-Sm (SLE), anti-CCP (RA) Imaging: - CXR: infection, mediastinal mass - contrast CT abdo/neck/pelvis- staging - PET- mets - Echo- cardiotoxic chemo baseline
Describe the microscopic features of HL?
- Reed-Sternberg cells (tumour giant cells of stunted group without hypermutation -> cannot express IgG): bilobed nuclei (owl eyed), prominent neuclosus
- RS variants: lacunar cells (nodular sclerosis) and popcorn cells (lymphohistiocytic variant)
What are the different HL subtypes?
Classic HL (95%)
- Nodular sclerosis (70%)- LN divided fibrosis bands w Lacunar cells
- Mixed cellularity (25%)- eosinophil increased (IL5)
- Lymphocyte-rich (5%)- lots of lymphocytes, normal RS cells, best prognosis
- Lymphocyte-depleted (<1%)- less lymphocytes, normal RS cells, worst prognosis
Nodular lymphocyte-predominant HL (5%)
- popcorn cells (RS variant)
Compare HL and NHL?
HL (40%):
Epi: young adults, >70yo
Histo: intermittent malignant cells (RS and variants)
Path: B-cell malignancy
Clinical: B symptoms (RS secrete cytokines)
LNs: cervical, supraclavicular, axilla
Spread: contiguous, mets/extranodal involvement less common
Risk: EBV, FMHx
Rx: Better Rx response. Stage 1-2 radiotherapy, stage 3-4 chemo
NHL (60%): Epi: >50yo Histo: big masses of malignant cells Path: B, T or NK cell malignancy Clinical: less type B symptoms LN: many groups Spread: haem, non-contiguous, mets/extranodal involvement common Risk: eviro (UV, radiation, chemicals), infection (EBV), immunosuppression (malnutrition, HIV), AI (SLE, RA), male, elderly, FMHx Rx. Poorer response, chemo
How is HL staged? What does stage IIA mean?
Ann-Arbor staging system:
I- single LN region or single extranodal site
II- 2 or more LN regions on same side of diaphragm
III- LN regions on both sides of diaphragm
IV- non-contigous involvement of one or more extralymphatic site
A- no B symptoms
B- B symptoms <6 months (weight loss >10%, recurrent/persistent fever), night sweats)
X- bulky disease (>6cm)
E- extension to single extralymphatic organ
Therefore: IIA means two or more affected LN groups on one side of diaphragm, with no B symptoms
Why is it more important to stage Hodgkin’s compared to Non-Hodgkin’s?
HL has contiguous and a more predictable spread -> staging has more prognostic value, can guide treatment
NHL tends to present with disseminated disease
- prognostic: grade, bone marrow involvement, B symptoms and the international prognostic index
Describe the histopathology of NHL?
E.g. Diffuse large B-cell lymphoma (most common NHL)
- poor differentiation, v aggressive
- neoplastic large B cells grow in sheets
- Heterogenous large cells w vesicular chromatic and prominent nuclei
Compare the prognosis of HL and NHL?
HL: 5yr survival 87%
- best prognosis in lymphocyte-rich subtype as Rx targets lymphocytes, worse in lymphocyte-depleted subtype
NHL: diffuse large B-cell 5yr survival 47%
Describe LN anatomy
Structure: small, bean-shaped masses of lymphoid tissue enclosed by a capsule of connective tissue that occur in association with the lymphatic vessels
- capsule: outer CT layer
- cortex (outer and inner): containing B cells (active in germinal centres of cortex, inactive in margin) and T cells (inner cortex)
- medulla: activated plasma cells
Function: filter for the blood, foreign antigens trapped and exposed to cells of the immune system for destruction